Evaluation the Activity of Antioxidants and Reproductive Performance for Allium cepa and Allium sativum Extracts on Males Rats Treated with Mycotoxins
DOI:
https://doi.org/10.53555/nnpbs.v4i4.695Keywords:
Allium cepa, Allium sativum, GOT, GPT, Testosterone and FSHAbstract
The present study has been designed to evaluate the beneficial effects of Allium cepa and Allium sativum extract upon Ochratoxin-induced hepatic toxicity, The study has been conducted on adult male rats during the period extended from February, 2017 to, July 2017. Fifty mature male Wister rats (aged 90 days and weighted 190±10 g),were divided in to Five randomly equal groups , the first served as negative control received only normal saline , the second as positive control received with contaminated with Asp. niger in diet as a single dose(2.5 mg/kg b.w). third group received with contaminated with Asp. niger as a single dose then treated after 2 days with Allium cepa (250 mg /kg b.w.) respectively orally through stomach tube during 42 days. fourth group received contaminated with Asp. niger as a single dose then treated after 2 days with Allium sativum (250 mg /kg b.w.) respectively orally through stomach tube for 42 days. Fifth group received contaminated with Asp. niger as a single dose then treated after 2 days with Allium cepa and Allium sativum together (250,250 mg /kg b.w.) respectively orally through stomach tube during 42 days. males were anaesthetized (by injection i/p of 0.3ml ketamine + 0.1 ml of xylazine /kg b. w. ip), blood samples were obtained from heart in non-heparinized tubes, Blood serum samples were separated for assessment of GOT, GPT, concentration, and assessment testosterone, FSH in blood serum. Under our experimental conditions, contaminated with Asp. niger resulted evidenced by statistically significant increase(p>0.05) in the activities of GOT, GPT in group 2 of just Ochratoxin compared with the control group, while in the third and fourth groups showed statistically significant decrease (p<0.05) in GOT, GPT level in Blood serum of contaminated with Asp. niger treated group compared with the control group, while in assessment of hormone shown in contaminated group showed decrease of this hormones as for as in Allium cepa and Allium sativum groups increase in hormones and in combination groups was very high significant in hormones levels. After histological analysis of the group contaminated with Asp. niger proved change in the, after the gavage of (Allium cepa and Allium sativum), and in testicular section was shown the effect of plants extract to repair of tissue. The results showed that there was an improvement in liver tissues after treatment with Allium cepa and Allium sativum. In present study we concluded to Allium cepa and Allium sativum together dose 250+250 mg/kg b.w. is better than dose 250mg/kg b.w. alone depending on results in recently study. we concluded that the administration of (Allium cepa and Allium sativum) together act as antifungal and antioxidant for contaminated with Asp. niger in males rats.
References
Barak, S.; Rajurkar, M.N.; Mallick, S.K. (2014). Detectionf of Blastocystis hominis: a controversial human pathogen. Parasitology Research, 113 (1): 261-265
Del Coco, V.F.; Molina, N.B.; Basualdo, J.A.; Córdoba, M.A. (2017). Blastocystis spp: avances, controversias y desafios. Revista Argentina de Microbiologia. http://dx.doi.org/10.1016/j.ram.2016.08.004
Hoffman WA, Pons JA, Janer JL. The sedimentation concentration method in schistosomiais. Puerto Rico Journal of Public health, 9: 281-298, 1934
Kaya, S.; Çetin, E.S.; Aridogan, B.C.; Arikan, S.; Demirci, M. (2007). Pathogenicity of Blastocystis hominis, a clinical reevaluation. Turkiye ParazitolDerg, 31 (3): 184-187
Kurt, O.; Al, F.D.; Tanyuksel, M. (2016). Eradication of Blastocystis in humans: really necessary for all? Parasitology International, 65 (6): 797-801
Minuzzi, T.T.C.S. & Cuba Cuba, C.A. (2010). Identificação Fenotípica de Dientamoeba fragilis e Blastocystis hominis em pacientes atendidos no ambulatório do Hospital Universitário de Brasília: Caracterização Molecular preliminar de isolados diagnosticados. Rev. Ibero-Latinoam. Parasitol., 69(2): 124-133
Nagel R; Gray, C.; Bielefeldt-Ohmann, H.; Traub, R.J. (2015). Features of Blastocystis spp. in xenic culture of revealed by deconvolutional microscopy. Parasitology Research, 114: 3237-3245
Sandpool, O. et al (2017). Subtype identification of human Blastocystis spp isolated from Lao People´s Democratic Republic. Acta Tropica, 168: 37-40
Silva, A.A. (2006). Incidência de Blastocystis hominis na População da Cidade do Rio de Janeiro, RJ. Newslab, 76: 86-96
Silva-Neto, L.M. et al (2010). Ocorrência de Blastocystis hominis e outros parasitos intestinais em uma comunidade de Paracambi-RJ no período de abril-julho de 2005. Revista de Patologia Tropical, 39 (2): 105-113
Tan, K.S. (2008). New insights on classification, identification and clinical relevance of Blastocystis spp. Clinical Microbiology Reviews, 21 (4): 639-665
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.